A Randomized, Double-blind, Cross-over Study to Assess Efficacy of 5-Aminolevulinic Acid in Type 2 Diabetic Patients on Medication.
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2012 New trial record